This inventor holds 0 USPTO granted patents, plus 1 CIPO patent.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Title: Bevyn Jarrott: Innovator in Flavonoid Compounds
Introduction
Bevyn Jarrott is a notable inventor based in Australia, recognized for her contributions to the field of flavonoid compounds. Her work focuses on novel flavonoid compounds that exhibit anti-oxidant activity, which have significant implications in various medical applications.
Latest Patents
Bevyn Jarrott holds a patent titled "Flavonoid Compounds And Uses Thereof." This patent describes novel flavonoid compounds that have been shown to exhibit anti-oxidant properties. These compounds are particularly useful in the treatment of ischemia and reperfusion injuries. The patent also outlines a method for chemically synthesizing these flavonoid compounds and testing their efficacy. The compounds and their corresponding pharmaceutically acceptable derivatives and/or salts have applications in pharmaceuticals, nutraceuticals, and veterinary fields.
Career Highlights
Throughout her career, Bevyn Jarrott has worked with several organizations, including Neuprotect Pty Ltd and the Howard Florey Institute. Her experience in these institutions has contributed to her expertise in the development of flavonoid compounds.
Collaborations
Bevyn has collaborated with notable individuals in her field, including Gregory James Dusting and Owen Llewellyn Woodman. These collaborations have further enhanced her research and development efforts.
Conclusion
Bevyn Jarrott is a pioneering inventor whose work on flavonoid compounds has the potential to impact various medical fields significantly. Her innovative approach to synthesizing and utilizing these compounds showcases her dedication to advancing scientific knowledge and applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile